Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Antifolate Drugs in Cancer Therapy, Hardback Book

Antifolate Drugs in Cancer Therapy Hardback

Edited by Ann L. Jackman

Part of the Cancer Drug Discovery and Development series

Hardback

Description

Antifolates are an important class of anticancer drugs originally developed as anti leu- kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar- comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase.

Furthermore, folate supplementation in the form of leucovorin, modulates 5-fluororuacil activity. 5-Fluorouracil is widely used in the treatment of colorectal and gastric cancer and in combination for other solid tumors such as breast and head and neck cancers.

Ongoing clinical trials with the newer antifolates suggest that the range of solid tumors where these agents will be of use may broaden further.

Half a century ago, interesting scientific and clinical discoveries suggested that folie acid was a vitamin involved in vital cellular metabolic processes. The folate analogs, aminopterin and methotrexate, were synthesized by the American Cyanamid Company in an attempt to interfere with these processes and were shown to have anticancer activity by Farber and his colleagues.

Hence, the principle of antimetabolite therapy for the treatment of cancer was established.

Biomedical research over the following years led to a deeper understanding of the complex biochemical pharmacology of folates and antifolates.

Selective antimicrobial agents were discovered, but more tumor-selective anticancer agents did not immediately emerge.

Information

  • Format:Hardback
  • Pages:456 pages, 13 Illustrations, black and white; X, 456 p. 13 illus.
  • Publisher:Humana Press Inc.
  • Publication Date:
  • Category:
  • ISBN:9780896035966
Save 14%

£199.99

£171.75

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

  • Format:Hardback
  • Pages:456 pages, 13 Illustrations, black and white; X, 456 p. 13 illus.
  • Publisher:Humana Press Inc.
  • Publication Date:
  • Category:
  • ISBN:9780896035966